***SHMN S/S TA Share structure below as of 5/21/2018***
Authorized: 2,000,000,000
Issued: 1,547,798,629 NO CHANGE
Restricted: 300,014,239 NO CHANGE
SOHM, Inc.
SHMN (OTC PINK)
About
Sohm, Inc. is a globally recognized Pharmaceutical company focused on developing, manufacturing and distributing Generic, Branded Generic, Private label, and Sohm innovated Pharmaceuticals, Cosmeceuticals and Nutraceutical products. The Company has its U.S. headquarters located in Buena Park, CA with international headquarters (Sohm India Pvt Ltd) located in Ahmedabad, India as well as several corporate offices located within the UK and China.
Sohm Inc. was voted the fastest growing generics prescription drug manufacturer in 2012 at the 30th All India Conference of National Integrated Medical Association. Sohm develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in several countries.
Sohm is committed to strict adherence of all applicable regulatory requirements and to the highest degree of industry standards. We are committed to maintaining quality by all employees at all levels throughout our corporation. Sohm ensures compliance by continuous assessment and monitoring of the output of the existing quality systems, and application of evolving industry guidelines and regulations including all WHO-CGMP and USFDA guidelines.
Sohm also offers and encourages businesses of any size all over the world to participate with the private labeling of generic pharmaceutical, cosmeceutical and nutraceutical products as part of its ongoing effort to integrate businesses and inspire global prosperity.
Investors
The Board of Directors of SOHM, Inc. believes that shareholder confidence in the Company, its management and financial reporting is critical to the success of the Company. This website provides general information regarding the corporate business activities of the Company. Further information can be obtained at www.otcmarkets.com
The Board also believes that good governance practice enhances confidence in our management team, financial information and employees. It creates a solid foundation for achieving our business goals and enables the Company to operate at the highest ethical standards. The Board has adopted actions that seek to ensure full compliance with the listing standards of the pinksheets electronic listing service.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
NEWS
https://www.sohm.com/2017/04/28/sohm-inc-signs-strategic-alliance-with-manufacturing-unit-in-southern-california-to-increase-revenue/
SOHM Inc., Signs Strategic Alliance with Manufacturing Unit in Southern California To Increase Revenue.
Partnerships and Alliances To Strengthen Market Penetration and Revenue Growth in Year 2017 and beyond.
Chino Hills, CA — April 27, 2017
SOHM, Inc. (PINKSHEETS: SHMN), a manufacturer of generic drugs covering all major treatment categories in Pharmaceutical, Nutraceutical and Cosmeceutical drug products announced today that it has signed a strategic alliance with a manufacturing unit in Southern California. This alliance strengthens SOHM’s manufacturing capabilities within the United States for distribution and export to other countries.
The company expects partnerships and alliances to strengthen market penetration and revenue growth in key emerging markets within the United States through its distribution channels. Alliance allows SOHM to double pharmaceutical production capability, reduce costs by several percent, increase profitability and restore its lost revenue from recent years. This alliance will make a positive impact on SOHM’s revenue by the end of Q3.
The strategic alliance with this manufacturing house currently has a range of 90 products covering major therapeutic categories. SOHM will utilize its spare manufacturing capacity of the manufacturing house.
“The manufacturing house facilities can produce all essential products in the dosage forms including tablets, capsules, flavored nutritional powders, sports energy drink powders, oral liquids, ointments, creams with excellent packing facilities, this will allow SOHM, Inc, USA to fulfill its growing market demand in the coming season and achieve the manufacturing volume growth needed to fulfill future purchase orders. This step also align company with current focus of USA to “Manufacturer in USA” by the government of USA and this will help to reduce operating costs and increase profitability.”
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
https://globenewswire.com/news-release/2017/11/29/1210569/0/en/SOHM-Inc-Cancellation-of-Reverse-Stock-Split.html
Cancellation of Reverse Stock Split
Chino Hills, CA, Nov. 28, 2017 (GLOBE NEWSWIRE)
SOHM, Inc. (PINKSHEETS: SHMN), announced today that its Board of Directors has decided to abandon and cancel the reverse stock split that was approved by the Board of Directors and the Company’s shareholders last year.
SOHM, Inc. announce today that “We are pleased to announce due to the obvious recent renewed support and confidence in the company and its management, it is in the best interest of the company, its shareholders and Investors to cancel the proposed reverse split of the common stock announced last year.” Recent support from operations and market awareness has further inspired company management to restore SOHM, Inc. to its former glory, benefitting investors and shareholders who have stood firmly by the company. SOHM presently has approximately 1.25 billion shares of common stock issued & outstanding SOHM Management has taken note of significant trade activity of its shares, and is very pleased with the recent movement in the company operation.
Further, company stated that company’s promoters or directors have not sold any of their stocks and have not done so for the last several years keeping the confidence in the company’s operations and not intending to sell any stocks currently.
Company is going to take appropriate actions with authorities to update the recent development and announcements.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia along with USA.
Forward-Looking Statements
This press release contains many forward-looking statements such as “project,” “plan,” “can,” etc. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
714-522-6700
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Chino Hills, CA, Nov. 29, 2017 (GLOBE NEWSWIRE)
I-Prolec™: Maximum Protein, Maximum Uptake
SOHM, Inc. (Pink Sheets: SHMN) is planning to launch a unique protein supplement “I-Prolec™” in to the American multibillion dollar supplement market. This unique product was a category defining product in India, and has very has good response from its consumers. I-Prolec™ is one of a long list of innovative products coming through the Sohm pipeline.
“This unique product, I-Prolec™, is formulated keeping in mind all the age groups and genders. I-Prolec™ will help people who have protein deficiency as well as athletes who need extra proteins, especially for those who adhere to a vegetarian diet”.
This special formulation of I-Prolec™ comes with and easy to absorb Vitamin B6, Vitamin B9, Iron (In the form of L Methyl Folate), plus all the minerals and vitamins that would make healthy living a reality. It has 23 different vitamins in a single dose. The fact that a single serving dosage is good enough for confirmed patient compliance made I-Prolec™ an instant hit amongst leading Gynecologists and Pediatricians in India as well as in retail nutraceutical market segment.
SOHM team believes that I-Prolec™ is not only a winning formula developed locally, but is also the most prolific protein supplement that SOHM is launching in USA and other important Global Markets in the coming months. With the introduction of I-Prolec™, SOHM will open a new stream of revenue. I-Prolec™ and products that are in the pipeline in this category would further consolidate the stability in revenue stream and ever-growing revenue generation in the coming months and especially in year 2018.
Company plans to sell and market this products through its distribution channels as well as retails online chain stores like Amazon and other reputable online stores.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia along with USA.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
https://globenewswire.com/news-release/2017/12/05/1229320/0/en/SOHM-Inc-Announces-Relaunch-of-Flagship-Skincare-Product-in-USA.html
SOHM, Inc., Announces Relaunch of Flagship Skincare Product in USA
Chino Hills, CA , Dec. 05, 2017 (GLOBE NEWSWIRE)
SOHM, Inc., (PINKSHEETS: SHMN) announced today a relaunch of its flagship skincare product FoHM by SOHM™, a rejuvenating, cleansing, and clarifying facial foam powered by SOHM’s proprietary formula Salic2™. This product was launched at an “after Oscar Party” in 2013 for the US market and had good market response however due to unavoidable circumstances, SOHM was not able to fully capitalize on its momentum.
FoHM by SOHM™ is a foaming facial cleanser and clarifier powered by Salic2™—SOHM’s propriety salicylic acid formulation. Originally, within the South Asian markets, this product was available only from dermatologists and doctors.
U.S. Relaunch of FoHM by SOHM™
So why transform a successful clinical product into an OTC (over-the-counter) product for U.S. consumption? “A number of things came together for us”
“First, we recognized that the American market is more mature and experienced with this type of product than markets we have been selling to in developing countries where acne, blackheads, and other skin conditions also are a problem. This will be manufactured within USA by SOHM’s Strategic Alliance company in Southern California.
“Second, in America we are taking the product direct to the consumer through online retail market places such as Amazon, and SOHM’s own online store. We are also in process with other online and brick and mortar retail chain stores for distribution and retail selling.
“However, third and most important to our decision was our innovation of a new delivery system. Normally, a 2% salicylic acid formulation is delivered as a gel or a cream. However, the Salic2 formula in FoHM by SOHM™ is a gentle but powerful foam delivery system that is perfect for the American consumer. Not only is it unique, but it is a more effective formulation than has been available.”
US OTC skin care market is multi-billion-dollar and with relaunch of this product, SOHM will create a new paradigm of success for it in the multi-billion-dollar skincare market, a space which “is expected to increase by 10%… driven by facial care,” according to Euromonitor International. We are especially enthusiastic about the unique delivery system of FoHM by SOHM™: a foam applicator that is not only convenient for women, but it makes this a product more likely to be used by men. We know that the more a product fits into the daily habits of a male consumer, the more successful he is to use it. Most women use skincare products, but most men don’t. At least, not before FoHM by SOHM™, which can be used by men for shaving!
With above introduction of product, SOHM expects fairly good organic growth in company revenues, its operation and bring full stability and growth in coming months and years.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
https://globenewswire.com/news-release/2017/12/05/1229369/0/en/SOHM-Inc-TO-ENTER-ICO-BITCOIN-MARKET.html
SOHM, Inc., TO ENTER ICO BITCOIN MARKET
Chino Hills, CA , Dec. 05, 2017 (GLOBE NEWSWIRE)
SOHM, Inc., (PINKSHEETS: SHMN) To enter ico bitcoin market. Updates to follow within a couple of days.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
https://www.sohm.com/2017/12/07/sohm-inc-announces-0-5m-purchase-order-for-a-range-of-pharmaceutical-products-in-2018/
SOHM, Inc., Announces $0.5m Purchase Order for a range of Pharmaceutical products in 2018.
CHINO HILLS, CA—December 7, 2017
SOHM, Inc. (PINKSHEETS: SHMN) is a globally-known generic pharmaceutical manufacturer, developer and marketer of a wide range of products serving a broad segment of the therapeutics market.
SOHM has received a purchase order, with an initial order of more than $0.5 million to supply a range of pharmaceutical products to one of its east coast customers, that will run through the end of 2018.
This new purchase order comes from a current customer that has executed purchase orders with SOHM through the end of 2017.
A spokesperson for SOHM, Inc., said, “SOHM is very pleased to have received this order from this customer that supplies retail and pharmacy networks all across the United States. This represents an annualized commitment to purchase and distribute 6 products other than SOHM products while providing SOHM a lucrative base to the huge American market for Generic Pharmaceuticals.
SOHM’s spokesperson said completion of this order would assure that SOHM achieves its target for higher revenue growth in 2018 compared to previous years.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
https://globenewswire.com/news-release/2018/01/19/1297892/0/en/SOHM-Inc-Executes-Non-Toxic-Funding-Commitment-with-Institutional-Investor-for-Expansion-of-Core-Business-to-Adopt-Blockchain-Technologies.html
SOHM, Inc., Executes Non-Toxic Funding Commitment with Institutional Investor for Expansion of Core Business to Adopt Blockchain Technologies
Chino Hills, Jan. 19, 2018 (GLOBE NEWSWIRE)
SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer, announces today that it has signed a binding Letter of Intent with a Canadian Institutional Investor for a sizable investment in SOHM. The proposed, non-toxic investment, is intended to further the Company’s core business model with a view to adopt blockchain technologies and the cryptocurrency markets; in particular, crypto mining and creating a synergistic token for the Company’s products and future services.
The Company previously announced it would explore those technology opportunities that would further SOHM’s value proposition. Management is confident that by incorporating blockchain technologies with its core business, SOHM will create a competitive advantage in the field of nutraceuticals. This will also afford the Company an ability to introduce new cosmeceutical and pharmaceutical products to the market.
Moreover, the introduction of blockchain technologies will support SOHM, if suitable, in pursuing a Token Generating Event (an Initial Coin Offering (ICO)) relative to the core business. In addition, the investment allows for crypto mining and other cryptocurrency endeavors.
A spokesperson for SOHM, Inc., said, “SOHM is very pleased to have the possibility of this investment for stability, expansion, growth and the development of those Blockchain technologies that should greatly improve shareholder confidence and Company advancement.”
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
SOHM, INC
Social Media, Corporate Info.
TWITTER FEED: https://twitter.com/sohminc?lang=en
FACEBOOK FEED: https://www.facebook.com/sohminc/
PRESS RELEASES (SOHM Website): https://www.sohm.com/category/press-releases/
OTC MARKETS: https://www.otcmarkets.com/stock/SHMN/profile
NVSOS: http://nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&nt7=0
NVSOS ACTIONS/AMENDMENTS: http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&CorpName=SOHM%2c+INC.
Contact info.
Website: http://www.sohm.com
Phone: (714) 522-6700
Address:
4195 Chino Hills Pkway
Ste 675
Chino Hills, CA 91709
Email: info@sohm.com